First-line therapeutic strategy for patients with advanced non–small cell lung cancer with Leu858Arg epidermal growth factor receptor mutations: a Bayesian network meta-analysis

AIM: The objective of this network meta-analysis was to determine the most useful first-line therapeutic strategy for patients with advanced (IIIB/IV or relapsed) non–small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) Leu858Arg or EGFR 19del mutations. METHODS: PubMed, the W...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Chongxiang, Zhang, Chunning, Lin, Huaming, Liu, Qianyin, Wu, Limian, Zhou, Chengzhi, Zhang, Jiexia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580106/
https://www.ncbi.nlm.nih.gov/pubmed/36274751
http://dx.doi.org/10.1177/20406223221125706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580106/
https://www.ncbi.nlm.nih.gov/pubmed/36274751
http://dx.doi.org/10.1177/20406223221125706

Ejemplares similares